Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| SLNH | 8-K | neutral | 2/10 | Soluna Holdings filed an 8-K announcing CEO John Belizaire will participate in the H.C. Wainwright 28th Annual Global In | Sep 9, 2026 |
| IXHL | 8-K | neutral | 4/10 | Incannex Healthcare provided a corporate update covering clinical progress, intellectual property, and a strong cash pos | Sep 9, 2026 |
| FTK | 8-K | bullish | 7/10 | Flotek Industries raised its FY2026 guidance for the second time, now expecting revenue of $360M-$370M (up from $340M-$3 | Sep 9, 2026 |
| RXO | 8-K | bullish | 5/10 | RXO provided a positive intra-quarter update, reporting that truckload gross profit per load increased by more than 10% | Sep 9, 2026 |
| IRD | 8-K | bullish | 7/10 | Opus Genetics reported positive 3- and 6-month data from the low-dose Cohort 1 of its Phase 1/2 trial for OPGx-BEST1 in | Sep 9, 2026 |
| TYRA | 8-K | bullish | 6/10 | Tyra Biosciences announced positive initial Phase 2 data for oral dabogratinib in FGFR3-altered low-grade intermediate-r | Sep 9, 2026 |
| DSAC | 8-K | bullish | 5/10 | Daedalus Special Acquisition Corp. (DSAC) announced a non-binding Letter of Intent to merge with HubX, a Turkish consume | Sep 9, 2026 |
| PYXS | 8-K | bullish | 6/10 | Pyxis Oncology announced positive updated Phase 1 monotherapy data for micvotabart pelidotin (MICVO) in second-line and | Sep 9, 2026 |
| LXU | 8-K | neutral | 3/10 | LSB Industries furnished an investor presentation highlighting strong financial performance (Q2'26 TTM net sales +22%, A | Sep 9, 2026 |
| CAL | 8-K | mixed | 6/10 | Caleres reported Q2 2026 adjusted EPS of $0.47, beating the $0.37 consensus by 27%, though revenue of $695.5M slightly m | Sep 9, 2026 |
| SER | 8-K | bullish | 6/10 | Serina Therapeutics announced that the Independent Safety Monitoring Committee completed its blinded review of Cohort 1 | Sep 9, 2026 |
| TENX | 8-K | neutral | 5/10 | Tenax Therapeutics presented a comprehensive update on its Phase 3 LEVEL trial of oral levosimendan (TNX-103) in PH-HFpE | Sep 9, 2026 |
| PWCM | 8-K | neutral | 3/10 | PowerCompute reported a monthly operational update for August 2026, showing consistent Bitcoin production of 7.9 BTC (fl | Sep 9, 2026 |
| AA | 8-K | mixed | 6/10 | Alcoa filed an 8-K announcing a proposed $2.6 billion senior notes offering to fund the cash portion of its $3.1 billion | Sep 9, 2026 |
| CTGO | 8-K | neutral | 3/10 | Contango Silver & Gold provided operational updates across its Alaska and British Columbia projects. Manh Choh mine's th | Sep 9, 2026 |
| IVDA | 8-K | bearish | 7/10 | Iveda Solutions received a second 180-day grace period from Nasdaq, extending the deadline to March 1, 2027, to regain c | Sep 9, 2026 |
| WW | 8-K | neutral | 4/10 | WW International appointed Stephen Bye as President, CEO, and a board member, effective by November 27, 2026. The new CE | Sep 9, 2026 |
| BTU | 8-K | mixed | 5/10 | Peabody Energy presented at the Jefferies Global Industrials Conference on September 10, 2026, providing an operational | Sep 9, 2026 |
| COCP | 8-K | neutral | 4/10 | Cocrystal Pharma announced that the last subject has been dosed in its Phase 1b norovirus challenge study (NCT07198139) | Sep 9, 2026 |
| NTRP | 8-K | neutral | 3/10 | NextTrip announced the international launch of its JOURNY TV and JOURNY Español travel entertainment channels on LG Chan | Sep 9, 2026 |
| LYFT | 8-K | neutral | 3/10 | Lyft announced the retirement of CFO Erin Brewer and the appointment of Michael Brous as her successor, effective Septem | Sep 9, 2026 |
| BALL | 8-K | neutral | 2/10 | Ball Corporation appointed Darlene Nicosia (CEO of Makers Pride) and Sherry Buck (former CFO of W.L. Gore) to its Board | Sep 9, 2026 |
| TTRX | 8-K | bullish | 5/10 | Turn Therapeutics appointed former CDC Director Dr. Robert R. Redfield as Chief Scientific Officer. This is a high-profi | Sep 9, 2026 |
| ASO | 8-K | bullish | 6/10 | Academy Sports & Outdoors reported Q2 FY2026 results with net sales of $1.647B (+3.0% YoY), GAAP diluted EPS of $2.17 (+ | Sep 9, 2026 |
| ADI | 8-K | bullish | 7/10 | Analog Devices (ADI) announced a definitive agreement to acquire Alif Semiconductor for $1.35 billion in cash, with up t | Sep 9, 2026 |
| GAME | 8-K | bullish | 7/10 | GameSquare Holdings (GAME) entered into a Contribution Agreement to acquire substantially all assets of FanEngine Holdin | Sep 9, 2026 |
| GAME | 8-K | neutral | 4/10 | GameSquare Holdings received a letter from Nasdaq on September 8, 2026, confirming it has regained compliance with the m | Sep 9, 2026 |
| AA | 425, 8-K | mixed | 6/10 | Alcoa announced a proposed $2.6B senior notes offering (two tranches: $1.3B due 2034 at assumed 6.75% and $1.3B due 2036 | Sep 9, 2026 |
| BIAF | 8-K | bullish | 6/10 | bioAffinity Technologies (BIAF) announced it has regained compliance with Nasdaq's minimum bid price rule (Listing Rule | Sep 9, 2026 |
| ECOR | 8-K | neutral | 3/10 | electroCore appointed Joshua Lev and Michael Fox as co-CEOs and Class III directors, effective September 8, 2026, with t | Sep 9, 2026 |